Please use this identifier to cite or link to this item: https://hdl.handle.net/1/1887
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBuckmaster, Adam-
dc.contributor.otherRoberts, C.T.-
dc.contributor.otherManley, B.J.-
dc.contributor.otherO'Shea, J.E.-
dc.contributor.otherStark, M.-
dc.contributor.otherAndersen, C.-
dc.contributor.otherDavis, P.G.-
dc.date.accessioned2020-10-27T00:30:41Z-
dc.date.available2020-10-27T00:30:41Z-
dc.date.issued2020-09-
dc.identifier.citation106(3):336-341en
dc.identifier.issn1359-2998en
dc.identifier.urihttps://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1887-
dc.description.abstractSurfactant is an effective treatment for respiratory distress syndrome, being particularly important for infants in whom continuous positive airway pressure (CPAP) provides insufficient support. Supraglottic airway devices present an attractive option for surfactant delivery, particularly as an alternative to methods dependent on direct laryngoscopy, a procedural skill that is both difficult to learn and in which to maintain competence. Published studies provide encouraging data that surfactant administration by supraglottic airway device can be performed with a high rate of success and may reduce the need for subsequent intubation compared with either continued CPAP or surfactant administration via endotracheal tube. However, existing randomised controlled trials (RCTs) are heterogeneous in design and include just over 350 infants in total. To date, all RCT evidence has been generated in tertiary units, whereas the greatest potential for benefit from the use of these devices is likely to be in non-tertiary settings. Future research should investigate choice and utility of device in addition to safety and effectiveness of procedure. Importantly, studies conducted in non-tertiary settings should evaluate feasibility, meaningful clinical outcomes and the impact that this approach might have on infants and their families. Supraglottic airway devices may represent a simple and effective mode of surfactant administration that can be widely used by a variety of clinicians. However, further well-designed RCTs are required to determine their role, safety and effectiveness in both tertiary and non-tertiary settings before introduction into routine clinical practice.en
dc.description.sponsorshipNeonatologyen
dc.subjectPediatricsen
dc.subjectPaediatricsen
dc.subjectNewborn and Infanten
dc.titleSupraglottic airway devices for administration of surfactant to newborn infants with respiratory distress syndrome: a narrative reviewen
dc.typeJournal Articleen
dc.identifier.doi10.1136/archdischild-2020-319804en
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/32989046/en
dc.description.affiliatesCentral Coast Local Health Districten
dc.description.affiliatesGosford Hospitalen
dc.identifier.journaltitleArchives of disease in childhood. Fetal and neonatal editionen
dc.type.studyortrialNarrative Reviewsen
dc.originaltypeTexten
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
Appears in Collections:Obstetrics / Paediatrics
Show simple item record

Page view(s)

88
checked on Mar 13, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.